BioSpace News Archive

Cellusion and Minaris Regenerative Medicine, a member of Showa Denko Materials, Enter into Business Alliance for the Manufacturing of CLS001 for a Corneal Endothelial Cell Regenerative Therapy

Cellusion Inc. and Minaris Regenerative Medicine, LLC announced Letter of Intent of the Manufacturing of CLS001 for a Corneal Endothelial Cell Regenerative therapy in the United States.

October 12, 2022
·
4 min read
Business

Philips provides update on its financial performance in Q3 2022

Amsterdam, the Netherlands – Royal Philips, a global leader in health technology, provided an update on its third-quarter 2022 financial results and full-year outlook.

October 12, 2022
·
4 min read
Policy

Approval of delisting of Vifor Pharma AG’s registered shares

Vifor Pharma AG announced that Vifor has received approval for the delisting of the totality of Vifor’s registered shares.

October 12, 2022
·
3 min read
Biotech Bay

Positive New Data for Genentech’s Evrysdi in Largest Trial Ever Undertaken in Patients With Previously-Treated Spinal Muscular Atrophy (SMA)

Genentech, a member of the Roche Group, announced new two-year data from the JEWELFISH study evaluating Evrysdi® in people with Type 1, 2 or 3 SMA aged 6 months to 60 years at time of enrollment.

October 12, 2022
·
10 min read
Drug Development

Poxel to Present DESTINY-1 Phase 2 Results for PXL065 in NASH at AASLD The Liver Meeting® 2022

POXEL SA announced that its late-breaking abstract describing the results from its Phase 2 study of PXL065 in NASH has been selected for an oral presentation at The Liver Meeting® 2022, hosted by the American Association for the Study of Liver Diseases, being held on November 4-8, 2022 in Washington, D.C.

October 12, 2022
·
6 min read
Drug Development

Amolyt Pharma to Present Full Phase 2a Data on AZP-3601 at Upcoming Conferences

Amolyt Pharma announced that it will be presenting data from its Phase 2a clinical trial at the 38th Congress of the French Society of Endocrinology to be held October 12-15, 2022 in Nantes, France, and the 2022 International HypoPARAthyroidism Conference to be held October 21-23, 2022 virtually.

October 12, 2022
·
3 min read
Business

Oliver Frank Appointed Vice President Phonak Marketing

Phonak, a leading global provider of life-changing hearing solutions, announces that Oliver Frank will be taking up the position as Vice President Phonak Marketing effective December 1, 2022.

October 12, 2022
·
1 min read
Angle PLC Announces First Regional Distribution Agreement

ANGLE plc, a world-leading liquid biopsy company, is pleased to announce it has signed a distribution agreement with Promedeus s.r.o to enable and support the roll out of the FDA cleared and CE marked Parsortix® PC1 system across the Czech Republic for its intended use in metastatic breast cancer.

October 12, 2022
·
7 min read
Immunovia announces positive update on physician experience program with IMMray™ PanCan-d

Immunovia AB announced positive feedback from its physician experience program for the IMMray™ PanCan-d test in the U.S., which is nearing completion.

October 12, 2022
·
3 min read
Drug Development

Sangamo Therapeutics Announces Updated Preliminary Phase 1/2 Data in Fabry Disease Showing Continued Tolerability and Sustained Elevated α-Gal A Enzyme Activity in Nine Patients

Sangamo Therapeutics, Inc., a genomic medicine company, announced updated preliminary results from the Phase 1/2 STAAR clinical study evaluating isaralgagene civaparvovec, or ST-920, a wholly owned gene therapy product candidate for the treatment of Fabry disease.

October 12, 2022
·
8 min read